Anavex Life Sciences Corp (AVXL)

[rocalinda]

I believe that there is enough evidence already that A-273 may be, at minimum, better than the current standard of care for AD. If Biogen, although testing for MS, is pleased with their experiment results, no doubt they would want to pursue a true partnership deal for more than MS. It is all about the results folks. If good, no way to hold us back with BS arguments like: scam, photo co., 4 employees, bogus trials, promotional PRs, Missling's hair, etc. etc.

Enjoy the weekend longs! For those on the other side of the ledger, something for you to ponder on:

------
TWST: Regarding Biogen, can you elaborate a little bit on the agreement terms as to which party does what?

Dr. Missling: It is a material transfer agreement in which Biogen will explore ANAVEX 2-73 in an in-house remyelination experiment of multiple sclerosis at its own costs. We are just providing the compound. After that, the evaluation will take place depending on what the findings are, and then discussions are expected to continue from that point on.
---------------